Neuroendocrine and circadian aspects (melatonin and β-endorphin) of atopic dermatitis in the child

Pediatric Allergy and Immunology

Volumn 18, Issue 8, 2007, Pages 679-686

  Munoz Hoyos A ^a,c   Espin Quirantes C ^b   Molina Carballo, A ^a   Uberos, J ^a   Contreras Chova, F ^a   Narbona Lopez E ^a   Gutierrez Salmeron M J ^a  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^b Hosp Univ Ciudad de Jaén   (Spain)

^c UNIVERSITY OF GRANADA   (Spain)

Author keywords

endorphin; Atopic dermatitis; Children; Melatonin

Indexed keywords

BETA ENDORPHIN; MELATONIN;

ARTICLE; ATOPIC DERMATITIS; BLOOD LEVEL; CIRCADIAN RHYTHM; CONTROLLED STUDY; FEMALE; HUMAN; HYPOTHESIS; IMMUNE RESPONSE; INFANT; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE SYSTEM; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIOIMMUNOASSAY; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; BETA-ENDORPHIN; CHILD; CHILD, PRESCHOOL; CIRCADIAN RHYTHM; DERMATITIS, ATOPIC; FEMALE; HUMANS; MALE; MELATONIN; MIDDLE AGED; NEUROSECRETORY SYSTEMS; PINEAL GLAND;

EID: 36849088596     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/j.1399-3038.2007.00574.x     Document Type: Article

References (55)

1. Rajka G. Natural history and clinical manifestations of atopic dermatitis. Clin Rev Allergy 1986 : 4 : 3 26.
2. Leung DY, Bieber T. Atopic dermatitis. Lancet 2003 : 361 : 151 60.
3. Eigenmann PA. Clinical features and diagnostic criteria of atopic dermatitis in relation to age. Pediatr Allergy Immunol 2001 : 12 (Suppl. 14 69 74.
4. Allam JP, Bieber T, Novak N. Recent highlights in the pathophysiology of atopic eczema. Int Arch Allergy Immunol 2005 : 136 : 191 7.
5. Novak N, Bieber T. The role of dendritic cell subtypes in the pathophysiology of atopic dermatitis. J Am Acad Dermatol 2005 : 53 : S171 6.
6. Zdolsek HA, Jenmalm MC. Expression of the T-cell markers CD2 and CD28 in healthy and atopic children during the first 18 months of life. Pediatr Allergy Immunol 2003 : 14 : 169 77.
7. Masuda K, Katoh N, Okuda F, Kishimoto S. Increased levels of serum interleukin-16 in adult type atopic dermatitis. Acta Derm Venereol 2003 : 83 : 249 53.
8. Folster-Holst R, Henseler T, Wehde J, et al. Soluble CD30 plasma concentrations correlate with disease activity in patients with atopic dermatitis. Acta Derm Venereol 2002 : 82 : 245 8.
9. Ader R. Psychoneuroimmunology. New York : Academic Press, 1991.
10. Ader R. Conditioned immunomodulation: research needs and directions. Brain Behav Immun 2003 : 17 (Suppl. 1 S51 7.
11. Carrillo-Vico A, Garcia-Maurino S, Calvo JR, Guerrero JM. Melatonin counteracts the inhibitory effect of PGE2 on IL-2 production in human lymphocytes via its mt1 membrane receptor. FASEB J 2003 : 17 : 755 7.
12. García-Maurino S, Pozo D, Calvo JR, Guerrero JM. Correlation between nuclear melatonin receptor expression and enhanced cytokine production in human lymphocytic and monocytic cell lines. J Pineal Res 2000 : 29 : 129 37.
13. Hanifin JM. Atopic dermatitis in infants and children. Pediatr Clin North Am 1991 : 38 : 763 89.
14. Elliott ST, Hanifin JM. Lymphocyte response to phytohemagglutinin in atopic dermatitis. Arch Dermatol 1979 : 115 : 1424 6.
15. Pancones E, Hautman G. Aspectos Psicosomáticos de la Dermatitis Atópica. Madrid : CEA ediciones, 1992.
16. Abramovits W. Atopic dermatitis. J Am Acad Dermatol 2005 : 53 : S86 93.
17. Muñoz-Hoyos A, Rodríguez-Cabezas T, Molina-Carballo A, Martínez-Sempere JJ, Ruiz-Cosano C, Acuña-Castroviejo D. Melatonin concentration in the umbilical artery and vein in human preterm and term neonates and neonates with acute fetal distress. J Pineal Res 1992 : 13 : 184 91.
18. Rivkees SA. Mechanisms and clinical significance of circadian rhythms in children. Curr Opin Pediatr 2001 : 13 : 352 7.
19. Muñoz-Hoyos A, Molina-Carballo A, Molina Font JA, Fernández-García JM, Acuña-Castroviejo D. Melatonina: Realidad actual y posibilidades futuras en Pediatría. Jaén : Alcalá Formación, 2002.
20. Wetterberg L. Melatonin in humans physiological and clinical studies. J Neural Transm Suppl 1978 : 13 (S) : 289 310.
21. Reiter RJ. Melatonin: clinical relevance. Best Pract Res Clin Endocrinol Metab 2003 : 17 : 273 85.
22. Petrovsky N, Harrison LC. The chronobiology of human cytokine production. Int Rev Immunol 1998 : 16 : 635 49.
23. Del Gobbo V, Libri V, Villani N, Calio R, Nistico G. Pinealectomy inhibits interleukin-2 production and natural killer activity in mice. Int J Immunopharmacol 1989 : 11 : 567 73.
24. Dimitrov S, Lange T, Tieken S, Fehm HL, Born J. Sleep associated regulation of T helper 1/T helper 2 cytokine balance in humans. Brain Behav Immun 2004 : 18 : 341 8.
25. Maestroni GJ. The immunotherapeutic potential of melatonin. Expert Opin Investig Drugs 2001 : 10 : 467 76.
26. García-Maurino S, González-Haba MG, Calvo JR, et al. Melatonin enhances IL-2, IL-6, and IFN-gamma production by human circulating CD4+ cells: a possible nuclear receptor-mediated mechanism involving T helper type 1 lymphocytes and monocytes. J Immunol 1997 : 159 : 574 81.
27. García-Maurino S, Pozo D, Carrillo-Vico A, Calvo JR, Guerrero JM. Melatonin activates Th1 lymphocytes by increasing IL-12 production. Life Sci 1999 : 65 : 2143 50.
28. Carrillo-Vico A, Lardone PJ, Fernández-Santos JM, et al. Human lymphocyte-synthesized melatonin is involved in the regulation of the interleukin-2/interleukin-2 receptor system. J Clin Endocrinol Metab 2005 : 90 : 992 1000.
29. Lardone PJ, Carrillo-Vico A, Naranjo MC, et al. Melatonin synthesized by Jurkat human leukemic T cell line is implicated in IL-2 production. J Cell Physiol 2006 : 206 : 273 9.
30. Lissoni P, Malugani F, Bordin V, Conti A, Maestroni G, Tancini G. A new neuroimmunotherapeutic strategy of subcutaneous low-dose interleukin-2 plus the long-acting opioid antagonist naltrexone in metastatic cancer patients progressing on interleukin-2 alone. Neuro Endocrinol Lett 2002 : 23 : 255 8.
31. Carrillo-Vico A, Calvo JR, Abreu P, et al. Evidence of melatonin synthesis by human lymphocytes and its physiological significance: possible role as intracrine, autocrine, and/or paracrine substance. FASEB J 2004 : 18 : 537 9.
32. Maestroni GJ, Sulli A, Pizzorni C, Villaggio B, Cutolo M. Melatonin in rheumatoid arthritis: synovial macrophages show melatonin receptors. Ann N Y Acad Sci 2002 : 966 : 271 5.
33. Miller SC, Pandi PS, Esquifino AI, Cardinali DP, Maestroni GJ. The role of melatonin in immuno-enhancement: potential application in cancer. Int J Exp Pathol 2006 : 87 : 81 7.
34. Silva SO, Rodrigues MR, Ximenes VF, Bueno-Da-Silva AE, Marante-Mendes GP, Campa A. Neutrophils as a specific target for melatonin and kynuramines: effects on cytokine release. J Neuroimmunol 2004 : 156 : 146 52.
35. Silva SO, Rodrigues MR, Carvalho SR, Catalani LH, Campa A, Ximenes VF. Oxidation of melatonin and its catabolites, N1-acetyl-N2 -formyl-5- methoxykynuramine and N1-acetyl-5-methoxykynuramine, by activated leukocytes. J Pineal Res 2004 : 37 : 171 5.
36. Lakin ML, Miller CH, Stott ML, Winters WD. Involvement of the pineal gland and melatonin in murine analgesia. Life Sci 1981 : 29 : 2543 51.
37. Lowenstein PR, Pereyra EN, Gonzalez SC, Cardinali DP. Effect of naloxone on the nocturnal rise of rat pineal melatonin content. Eur J Pharmacol 1984 : 98 : 261 4.
38. Molina-Carballo A, Acuña-Castroviejo D, Rodríguez-Cabezas T, Muñoz-Hoyos A. Effects of febrile and epileptic convulsions on daily variations in plasma melatonin concentration in children. J Pineal Res 1994 : 16 : 1 9.
39. Weber RS, Pert CB. Opiatergic modulation of the immune system. In : Miller EE, Genassani AR, eds. Central and Peripheral Endorphins: Basic and Clinical Aspects. New York : Raven Press, 1984 : 35 41.
40. Lissoni P, Esposti D, Esposti G, et al. A clinical study on the relationship between the pineal gland and the opioid system. J Neural Transm 1986 : 65 : 63 73.
41. Srinivasan V, Maestroni GJ, Cardinali DP, Esquifino AI, Pandi-Perumal SR, Miller SC. Melatonin, immune function and aging. Immun Ageing 2005 : 2 : 17.
42. Maestroni GJ, Conti A, Pierpaoli W. Pineal melatonin, its fundamental immunoregulatory role in aging and cancer. Ann N Y Acad Sci 1988 : 521 : 140 8.
43. Lynch HJ, Deng MH. Pineal responses to stress. J Neural Transm Suppl 1986 : 21 : 461 73.
44. Muñoz-Hoyos A, Molina-Carballo A, Rodríguez-Cabezas T, Uberos-Fernández J, Ruiz-Cosano C, Acuña-Castroviejo D. Relationships between methoxyindole and kynurenine pathway metabolites in plasma and urine in children suffering from febrile and epileptic seizures. Clin Endocrinol (Oxf) 1997 : 47 : 667 77.
45. Cohen MR, Pickar D, Dubois M, Cohen RM. Studies of the endogenous opioid system in the human stress response. In : Plotnikoff NP, Murgo AJ, eds. Enkephalins and Endorphins: Stress and the Immune System. New York : Plenum Press, 1986.
46. Girón-Caro F, Muñoz-Hoyos A, Ruiz-Cosano C, et al. Melatonin and beta-endorphin changes in children sensitized to olive and grass pollen after treatment with specific immunotherapy. Int Arch Allergy Immunol 2001 : 126 : 91 6.
47. Maestroni GJ, Conti A, Pierpaoli W. The pineal gland and the circadian, opiatergic, immunoregulatory role of melatonin. Ann N Y Acad Sci 1987 : 496 : 67 77.
48. Madden JJ, Donahue RM, Smith IE. Kinetics of Erythrocyte Rosette Formation with Lymphocytes from drug-addicted subjects. In Harris LS. (ed) : Problems of Drug Dependence, National Institute on Drug Abuse, Res. Monograph, 1983 : 43 : 375 9.
49. Wybran J, Appelboom T, Famaey JP, Govaerts A. Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood T lymphocytes. J Immunol 1979 : 123 : 1068 70.
50. Schwarz W, Birau N, Hornstein OP, et al. Alterations of melatonin secretion in atopic eczema. Acta Derm Venereol 1988 : 68 : 224 9.
51. McMillen IC, Nowak R. Maternal pinealectomy abolishes the diurnal rhythm in plasma melatonin concentrations in the fetal sheep and pregnant ewe during late gestation. J Endocrinol 1989 : 120 : 459 64.
52. Kunkel G, Paus R, Polson R, Szentivanyi A. Beta-adrenergic receptors in nasal tissue with reference to their role in asthma and atopy. Allergol Immunopathol (Madr) 1989 : 17 : 67 72.
53. Wright RJ, Cohen RT, Cohen S. The impact of stress on the development and expression of atopy. Curr Opin Allergy Clin Immunol 2005 : 5 : 23 9.
54. Cikler E, Ercan F, Cetinel S, Contuk G, Sener G. The protective effects of melatonin against water avoidance stress-induced mast cell degranulation in dermis. Acta Histochem 2005 : 106 : 467 75.
55. Maestroni GJ. T-helper-2 lymphocytes as a peripheral target of melatonin. J Pineal Res 1995 : 18 : 84 9.